skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines rivastigmineQuestion & answer

rivastigmine · Medicine question

What condition are Exelon rivastigmine patches licensed to treat?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Exelon rivastigmine patches are licensed for the symptomatic treatment of mild to moderately severe Alzheimer's dementia.

Sources for this answer

Exelon 4.6 mg/24h, 9.5 mg/24h, 13.3 mg/24h transdermal patchNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 21Document updated 22 October 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about rivastigmine

What are the most frequently observed side effects of Exelon rivastigmine patches?What precautions apply to prolonged exposure of Exelon rivastigmine patches to external heat sources?Can rivastigmine interfere with the activity of oxybutynin or tolterodine?Can women taking rivastigmine breast-feed?How can rivastigmine affect succinylcholine-type muscle relaxants during anaesthesia?How can rivastigmine affect the ability to drive or operate machinery?

rivastigmine

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the rivastigmine guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX